Search peptides, terms, sources/
4 peptides

Melanocortin

Melanocortin peptides act on a family of receptors that affect skin pigmentation, appetite and sexual function. Two are licensed UK medicines for rare conditions: afamelanotide, for a rare light-sensitivity disorder, and setmelanotide, for rare genetic and hypothalamic forms of obesity. No UK marketing authorisation was found for Melanotan II or PT-141 (bremelanotide). Their evidence differs greatly in size and quality, and evidence for one does not carry over to another.

Which peptides are in this family?

  • Afamelanotide

    Synthetic alpha-MSH analogue studied in erythropoietic protoporphyria (EPP). Licensed in the UK for adults with EPP; not recommended for routine NHS use. Not the same as Melanotan II.

    MelanocortinHuman trialsEvidence reviewed
    ModerateLicensed UK medicine
  • Melanotan IIMT-II

    Synthetic melanocortin receptor agonist studied for skin tanning. Not licensed in the UK; human evidence is a three-volunteer pilot plus case reports.

    MelanocortinHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • PT-141 (Bremelanotide)Bremelanotide

    No UK marketing authorisation found; authorised in the US. Selective melanocortin-4 receptor agonist studied for low sexual desire in women.

    MelanocortinHuman trialsEvidence reviewed
    StrongNot licensed in the UK
  • Setmelanotide

    Synthetic peptide that activates the MC4 receptor, studied in rare forms of obesity. UK prescription-only medicine for three rare conditions; trials were small and do not cover common obesity.

    MelanocortinHuman trialsEvidence reviewed
    ModerateLicensed UK medicine

Best recorded finding for each peptide in this family

Each row grades one recorded finding, not the peptide or the medicine.

PeptideUK statusFindingEvidence grade
AfamelanotideLicensed UK medicineTwo phase 3 trials in EPPModerate
Melanotan IINot licensed in the UKNaevi and melanoma case reportsLimited
PT-141 (Bremelanotide)Not licensed in the UKThe RECONNECT Phase 3 trialsStrong
SetmelanotideLicensed UK medicineAcquired hypothalamic obesityModerate

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.